邢泰昂,燕华玲

克立硼罗软膏作为一款新型小分子磷酸二酯酶4（PDE-4）抑制剂，具有非激素、非甾体类抗炎特性，近年来在皮肤科治疗领域备受关注。该药物目前已被批准用于轻中度特应性皮炎的一线治疗，同时在银屑病、白癜风等其他炎症性皮肤病的治疗中也展现出潜在的应用价值。本文将从三个维度系统阐述克立硼罗的作用机制、临床应用及前沿研究。

克立硼罗软膏；磷酸二酯酶4抑制剂；皮肤病；治疗

[1] Tracy A,Bhatti S,Eichenfield L.Update on pediatric atopic dermatitis[J].Cutis,2020,106(3):143-146. [2] Peng T,Qi B,He J,et al.Advances in the Development of Phosphodiesterase-4 Inhibitors[J].Med Chem.2020 63(19):10594-10617. [3] Jarnagin K,Chanda S,Coronado D,et al.Crisaborole topical ointment,2%:a nonsteroidal,topical,anti-inflammatory phosphodiesterase 4 inhibitor in clinical development for the treatment of atopic dermatitis[J].J Drugs Dermatol,2016,15(4):390-396. [4] Matin T,Logas CM,Glick BP,et al.Introduction to atopic dermatitis[J].Dermatological Reviews.2022;3:3-4. [5] 中华医学会皮肤性病学分会免疫学组,特应性皮炎协作研究中心.中国特应性皮炎诊疗指南(2020版)[J].中华皮肤科杂志, 2020,53(2):81-88. [6] Bissonnette R,Pavel AB,Diaz A,et al.Crisaborole and atopic dermatitis skin biomarkers:an intrapatient randomized trial[J].J Allergy Clin Immunol,2019,144(5):1274-1289. [7] Paller AS,Tom WL,Lebwohl MG,et al.Efficacy and safety of crisaborole ointment,a novel,nonsteroidal phosphodiesterase 4(PDE4) inhibitor for the topical treatment of atopic dermatitis(AD)in children and adults[J].J Am Acad Dermatol,2016,75(3):494-503.e6. [8] Eichenfield LF,Call RS,Forsha DW,et al.Long-term safety of crisaborole ointment 2%in children and adults with mild to moderate atopic dermatitis[J].J Am Acad Dermatol,2017,77(4):641-649.e5. [9] Schlessinger J,Shepard JS,Gower R,et al.Safety,effectiveness,and pharmacokinetics of crisaborole in infants aged 3 to<24 months with mild-to-moderate atopic dermatitis:a phaseⅣopen-label study(CrisADe CARE 1)[J].Am J Clin Dermatol,2020,21(2):275-284. [10] Yang H,Wang J,Zhang X,et al.Application of Topical Phosphodiesterase 4 Inhibitors in Mild to Moderate Atopic Dermatitis:A Systematic Review and Meta-analysis[J].Dermatol.2019 May 1;155(5):585-593. [11] Draelos Z D,Ports W C,Vlahos B,et al.Skin permeation and penetration of crisaborole when oapplied with emollients[J].J Am Acad Dermatol,2020,83(6):1801-1803. [12] Puar N,Chovatiya R,Paller A S.New treatments in atopic dermatitis[J].Ann Allergy Asthma Immunol,2021,126(1):21-31. [13] 吕莉,陈敬.银屑病治疗的研究进展[J].河北医药,2017,39(23):3643-3647. [14] Hashim PW,Chima M,Kim HJ,et al.Crisaborole 2%ointment for the treatment of intertriginous,anogenital,and facial psoriasis:a double-blind,randomized,vehicle-controlled trial[J].J Am Acad Dermatol,2020,82(2):360-365. [15] Liu Y,Li W.Crisaborole ointment as treatment for genital psoriasis[J].J Cosmet Dermatol,2022,21(9):4080-4081. [16] Lee EB,Lebwohl MG,Wu JJ.Treatment of psoriasis with crisaborole[J].J Dermatolog Treat,2019,30(2):156-157. [17] Liu Y,Li W.Successful treatment with crisaborole for facial lesions refractory to adalimumab in a man with psoriasis:a case report[J].Dermatol Ther,2022,35(5):e15424. [18] Robbins AB,Gor A,Bui MR.Topical crisaborole-a potential treatment for recalcitrant palmoplantar psoriasis[J].JAMA Dermatol,2018,154(9):1096-1097. [19] Tausend W,Hoyer P,Arnold M,et al.Successful treatment of vitiligo with crisaborole 2%ointment[J].Skin J Cutan Med,2019,3:111. [20] Tam I,Kahn JS,Rosmarin D.Repigmentation in a patient with vitiligo on crisaborole 2%ointment[J].JAAD Case Rep,2021,11:99-101. [21] Peña SM,Oak ASW,Smith AM,et al.Topical crisaborole is an efficacious steroid-sparing agent for treating mild-to-moderate seborrhoeic dermatitis[J].Eur Acad Dermatol Venereol.2020 Dec;34(12):e809-e812. [22] Liu D,Chow P,Strawn S,et al.Chronic nasolabial fold seborrheic dermatitis successfully controlled with crisaborole[J].J Drugs Dermatol,2018,17(5):577-578. [23] Alkhalifah A,Fransen F,Le Dufe F,et al.Laser treatment of epidermal nevi:A multicenter retrospective study with long-term follow-up[J].J Am Acad Dermatol,2020,83(6):1606-1615. [24] Li Z,Liu Q,Zhang F,et al.Successful treatment of generalized inflammatory linear verrucous epidermal nevus with a somatic mutation in KRT10 with crisaborole 2%ointment[J].Clin Exp Dermatol.2025 Feb 5:llaf059. [25] Zou Y,Yu L,Xue J,et al.Molecular mechanism of crisaborole combined with erythromycin against methicillin-resistant Staphylococcus aureus in vivo and in vitro[J].Front Microbiol.2025 Feb 27;16:1503515. [26] Zheng M,He P,Luo L,et al.Atypical necrobiosis lipoidica of the face and scalp successfully treated with combined baricitinib and crisaborole[J].J Dermatol.2025 Apr;52(4):e286-e287. [27] Liu X,Liu Q,Guo L,et al.2%Crisaborole Ointment for the Treatment of Chronic Cheilitis Caused by Lip Tattoos[J].J Inflamm Res.2024 May 27;17:3419-3422. [28] Li L.Clinical efficacy evaluation of crisaborole ointment in the treatment of vulvar leukoplakia[J].Rev Assoc Med Bras(1992).2023 Feb 17;69(1):97-100. [29] Liang Y,Liang J,Huang Q,et al.Knuckle Pads Successfully Treated with 2%Crisaborole Ointment Combined with Triamcinolone Acetonide and Neomycin Plaster:A Case Report[J].Clin Cosmet Investig Dermatol.2023 Jul 24;16:1893-1897.

点击下载PDF